Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia

  title={Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia},
  author={Denis S. Baranovskii and Ilya D. Klabukov and Olga Aleksandrovna Krasilnikova and Dimitri A. Nikogosov and Natalia V. Polekhina and Delyara R. Baranovskaia and L. A. Laberko},
  journal={Current Medical Research and Opinion},
  pages={1 - 8}
Abstract Background Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. The evaluation of laboratory findings including coagulation and inflammation parameters may represent a promising approach for early determination of COVID-19 severity. Methods and Materials In the present study, we aimed to identify laboratory parameters present upon… 
3 Citations
Individual Characteristics as Prognostic Factors of the Evolution of Hospitalized COVID-19 Romanian Patients: A Comparative Observational Study between the First and Second Waves Based on Gaussian Graphical Models and Structural Equation Modeling
The main results highlight that the specific treatment methods applied had a positive influence on the evolution of COVID-19 patients, particularly in the second wave of coronavirus pandemic.
Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy
  • Feng Zhang, Wei Liu, +8 authors Guangbo Ge
  • Medicine
    Acta pharmacologica Sinica
  • 2021
Findings reveal that HEJG modulates the pharmacokinetics of CYP substrate-drug(s) by inactivating CYP3A, providing key information for both clinicians and patients to use herb–drug combinations for antiviral therapy in a scientific and reasonable way.


Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Fibrinogen seems to increase early in COVID-19 patients and may be used as a risk stratification marker for the early detection of a subgroup of CO VID-19 patient at increased risk to develop SARS, who might benefit from a different and thorough clinical surveillance and treatment.
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID‐19
This study conducted a meta‐analysis of 31 studies involving 7613 participants and found a significant association between thrombocytopenia and severe COVID‐19 hospitalized patients or poor outcome in this setting, however, other clinical, biological and radiological factors strongly impact CO VID‐19 outcome.
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Low platelet count is associated with increased risk of severe disease and mortality in patients with COVID-19, and thus should serve as clinical indicator of worsening illness during hospitalization.
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
Preliminary reports on COVID-19 patients’ clinical and laboratory findings include thrombocytopenia, elevated D-dimer, prolonged prothrombin time, and disseminated intravascular coagulation.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
A period of 7–13 days after illness onset is the critical stage in the COVID-19 course, which shows persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death.
COVID‐19 and the clinical hematology laboratory
The laboratory's role in the diagnosis of COVID‐19 infection is discussed, the current state of biomarker analysis in COVID'S infection is summarized, and the impact of the pandemic has had on organized national and international educational activities worldwide is described.
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk, including patients with cardiovascular comorbidity.
Coagulation and inflammation biomarkers may help predict the severity of community‐acquired pneumonia
The aim of this study was to evaluate the association between the severity of CAP and serum levels of antithrombin III (AT‐III), protein C (P‐C), D‐dimers (D‐D) and CRP, at hospital admission.
Coronavirus Disease - COVID-19
Community quarantine measures aimed at decreasing stress on health facilities through minimizing risk of infection, potentially resulting in lower morbidity and mortality and government finalizing National COVID-19 Contingency Plan complemented by Humanitarian Country Team Response Plan.